Chitosan microparticles as oral delivery system for tetanus toxoid

Drug Development and Industrial Pharmacy

Volumn 33, Issue 10, 2007, Pages 1112-1124

  Ahire, Vijay J ^a   Sawant, Krutika K ^a   Doshi, Jignesh B ^b   Ravetkar, Satish D ^b  

^a M S UNIVERSITY OF BARODA   (India)

^b Serum Institute of India Ltd   (India)

Author keywords

Chitosan; Mucosal and systemic immunity; Tetanus toxoid

Indexed keywords

CHITOSAN; HYDROCHLORIC ACID; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PHOSPHATE BUFFERED SALINE; TETANUS TOXOID; TRIPOLYPHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CROSS LINKING; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEEDING; IMMUNE RESPONSE; INTESTINE LAVAGE; NONHUMAN; SEDIMENTATION; TETANUS; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; CHITOSAN; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG DELIVERY SYSTEMS; HYDROGEN-ION CONCENTRATION; MICE; MICE, INBRED BALB C; MICROSPHERES; PARTICLE SIZE; PROTEIN CONFORMATION; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TETANUS TOXOID; VACCINATION; VISCOSITY;

EID: 35649013865     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701377847     Document Type: Article

References (39)

1. Ahire, V. J., Sawant, & K. K. (2006). Development of Rocket Electrophoresis Technique as an Analytical Tool in Preformulation Study of Tetanus Vaccine Formulation.Drug Dev. Ind. Pharm., 32(7), 799-808.
2. Alpar, H. O., Eyles, J., & Williamson, E. (1998). Oral and nasal immunization with microencapsulated clinically relevant proteins. STP Pharma. Sci., 8, 31-9.
3. Barackman, J. D., Singh, M., Ugozoli, M., Ott, G. S., & O'Hagan, D. T. (1998). Oral immunization with poly(lactide-co-glycolide) microparticles containing an entrapped recombinant glycoprotein(gD2) from Herpes Simplex type 2 virus. STP Pharma. Sci., 8, 41-46.
4. Barichello, J. M., Moriko, M., Takayama, K, & Nagai, T. (1999). Encapuslation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev. Ind. Pharm. 25, 471-476.
5. Berger, J., Resist, M., Mayer, J. M., Felt, O., Peppas, N. A., & Gurny, R. (2004). Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur. J. Pharm. Biopharm. 57, 19-34.
6. Brack, H. P., Tirmizi, S. A., & Risen, W. M. (1998). A spectroscopic and viscometric study of the metal ion-induced gelation of the biopolymer chitosan. Polymer 38, 2351-2362.
7. Brange, J., & Langkjaer, L. (1992). Chemical stability of insulin, 3. Influence of excipients, formulation, and pH. Act. Pharm. Nord., 4, 149-158.
8. Calvo, P., Renuman-Lopez, C, Vila-Jato, J. L., & Alonso, M. J. (1997). Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J. Appl. Polym. Sci., 63, 125-132.
9. Chang, A. C., & Gupta, R. K. (1996). Stabilization of Tetanus Toxoid in Poly(DL-lactic-co-glycolic acid) Microspheres for the controlled release of antigen. J. Pharm. Sci., 85(2), 129-132.
10. Cho, N. H., Seong, S. Y., Chun, K. H., Kim, Y. H., Kwon, I., & Ahn, B. Y. (1998). Novel Mucosal immunization with polysaccharide-protein conjugates entrapped in alginate microspheres. J. Contr. Release., 53, 215-24.
11. Coppi, G., Iannuccelli, V., Leo, E., Bernabei, M. T., & Cameroni, R. (2002). Protein immobilization in crosslinked alginate microparticles. J. Microencap., 19(1), 37-44.
12. Damge, C., Aprahamian, M., Humbert, W., & Pinget, M. (2000). Ileal uptake of polyalkylcyanoacrylate nanocapsules in the rat. J. Pharm. Pharmacol., 52, 1049-1056.
13. Eldridge, J. H., Hammond, C. J., Meulbroek, J. A., Staas, J. K., Gilley, R. M., & Tice, T. R. (1990). Controlled release in the gut associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J. Contr. Release, 11, 205-214.
14. Elgersma, A. V., Zsom, R. L. J., Norde, W., & Lyklema, J. (1990). The adsorption of bovine serum albumin on positively and negatively charged polystyrene lattices. J. Colloid Int. Sci., 138, 145-156.
15. Esparaza, I., & Kissel, T. (1992). Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. Vaccine, 10(10), 714-720.
16. Forrest, B. D. (1992). Effects of sample processing on the measurement of specific intestinal IgA immune response. Vaccine, 10(11), 802-805.
17. Grewal, H. M. S., Karlsen, T. H., Vetvik, H., Ahren, C., Gjessing, H. K., Sommerfelt, H., & Haneberg, B. (2000). Measurement of specific IgA in fecal Extracts and intestinal lavage fluid for monitoring of mucosal immune responses. J. Immun. Methods, 239, 53-62.
18. Kim, S. Y., Doh, H. J., Ahn, J. S., Ha, Y. J., Jang, M. H., & Chung, S. I. (1999). Induction of mucosal and systemic immune response by oral immunization with H.pylori lysates encapsulated in poly(D,L-lactide-co- glycolide) microparticles. Vaccine, 17, 607-616.
19. Knaul, J. Z., Hudson, S. M., & Creber, K. A. M. (1999). Improved mechanical properties of chitosan fibers. J. Appl. Polym. Sci., 72, 1721-1731.
20. Lavelle, E. C., Yeh, M. K., Coombes, A. G. A., & Davis, S. S. (1999). The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycols. Vaccine, 17, 512-529.
21. Liu, W. G.; & Kang, D. Y. (2002). Chitosan and its derivatives - a promising nonviral vector for gene transfection. J. Contr. Release, 83, 1-11.
22. Ma, Z., Yeoh, H. H., & Lim, L. Y. (2002). Formulation pH modulates the interaction of Insulin with chitosan nanoparticles. J. Pharm. Sci., 91(6), 1396-1404.
23. Mi, F. L., Shyu, S. S., Wong, T. B., Jang, S. F., Lee, S. T., & Lu, K. T. (1999). Chitosan polyelectrolyte complexation for the preparation of gel beads and controlled release of anti-cancer drug. II Effect of pH-dependent ionic crosslinking or interpolymer complex using tripolyphosphate or polyphosphate as reagent. J. Apl. Polym. Sci., 74, 1093-1107.
24. O'Hagan, D. T. (1998). Microparticles and polymers for the mucosal delivery of vaccines. Adv. Drug Deliv. Rev., 34, 305-320.
25. Peyre, M., Sesardic, D., Merkle, H. P., Gander, B., & Johansen, P. (2003). An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria. J. Pharm. Sci., 92(5), 957-966.
26. Radi, H., & Mansoor, A. (2003). Chitosan based gastrointestinal delivery systems. J. Contr. Release, 89, 151-165.
27. Roberts, G. A. F. (1992). Chitin Chemistry, MacMillan Press: London; 203-206.
28. Shu, X. Z., Zhu, K. J., & Song, W. (2001). Novel pH-sensitive citrate cross-linked chitosan film for drug controlled release. Int. J. Pharm., 212, 19-28.
29. Simonsen, O., Bentzon, M. W., Kjeldson, K., Venborg, H. A., & Heron, I. (1987). Evaluation of vaccination requirements to secure continuous anti-toxin immunity to tetanus. Vaccine, 5, 115-122.
30. Singla, A. K., & Chawla, M. (2001). Chitosan : Some pharmaceutical and biological aspects - An update. J. Pharm. Pharmacol., 53, 1047-1067.
31. Spiers, I. D., Eyles, J. E., Baille, L. W. J., Williamson, E. D., & Alpar, H. O. (2000). Biodegradable microparticles with different release profiles: Effect on the immune response after a single administration via intranasal and intramuscular routes. J. Pharm. Pharmacol., 52, 1195-1201.
32. Tabata, Y., Inoue, Y., & Ikada, Y. (1996). Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres. Vaccine, 14(17/18), 1677-1685.
33. van der Lubben, I. M., Kersten, G., Fretz, M. M., Beuvery, C., Verhoef, J. C., & Junginger, H. E. (2003). Chitosan microparticles for Mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice. Vaccine, 21, 1400-1408.
34. van der Lubben, I. M., Verhoef, J. C., van Aelst, A., Borchard, G., & Junginger, H. E. (2001). Chitosan microparticles for oral vaccination preparation, characterization, and preliminary in vivo uptake studies in murine peyer's patches. Biomaterials, 22, 687-694.
35. Wassilak, S. G. F., Roper, M. H., Murphy, T. V., & Orenstein, W. A. (2002). Tetanus toxoid. In Plotkin, S. A., & Mortimer, E. A., (Ed.), Vaccines, (4th Ed.), Saunders: Philadelphia; 745-781.
36. WHO Regional Office for Europe. (1986). Immunization policies in Europe, Document ICP/EPI 001 m01.
37. Xing, D. K. L., McLellan, K., Corbel, M. J., & Sesardic, D. (1996). Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres. Biologicals 24, 57-65.
38. Xu, Y., & Du, Y. (2003). Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int. J. Pharm., 250, 215-226.
39. Yu, J. H., Du, Y. M., & Zheng, H. (1999). Blend films of chitosan-gelation. J. Wihan. Univ. (Nal. Sci. Ed.). 45, 440-444.